State of Wyoming’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-303
Closed -$5K 1852
2022
Q1
$5K Buy
303
+93
+44% +$1.59K ﹤0.01% 1655
2021
Q4
$5K Buy
210
+31
+17% +$1.34K ﹤0.01% 1717
2021
Q3
$13K Sell
179
-121
-40% -$8.06K 0.01% 991
2021
Q2
$16K Buy
300
+184
+159% +$11K 0.01% 960
2021
Q1
$9K Buy
+116
New +$9.13K 0.01% 395

Other funds holding ALXO

State of Wyoming's ALXO Position: Q2 2022 in Review

State of Wyoming sold out of ALX Oncology (ALXO) in Q2 2022, closing a stake of 303 shares — an estimated $5K sold.

State of Wyoming first reported a position in ALXO in Q1 2021 and held it in 5 quarters. The position peaked at $16K in Q2 2021. 97 funds tracked by Wall St. Rank hold ALXO as of Q2 2022.

  • State of Wyoming reported no remaining ALX Oncology position as of Q2 2022 after selling out during the quarter.
  • State of Wyoming sold 303 ALX Oncology shares in Q2 2022, an estimated $5K.
  • State of Wyoming first reported a position in ALX Oncology in Q1 2021 and held it in 5 quarters.
  • State of Wyoming's ALX Oncology position peaked at $16K in Q2 2021.
  • 97 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2022.

Based on State of Wyoming's 13F filing for Q2 2022, filed 15 Aug 2022.